ClinicalTrials.Veeva

Menu

Can the Femoral Nerve Block be Improved by Ultrasound Guidance?

NHS Trust logo

NHS Trust

Status and phase

Unknown
Phase 4

Conditions

Pain

Treatments

Procedure: loss of resistance
Procedure: determination of method with highest efficacy (ultrasound or nerve stimulator)
Procedure: nerve stimulator

Study type

Interventional

Funder types

Other

Identifiers

NCT00696150
CSO reference CAF/07/05
ultrasound for hip # study-1

Details and patient eligibility

About

Studies have suggested a link with effective pain relief and reduced illness and death in very unwell patients. This study will determine the most effective method of injecting local anaesthetic around the nerves which supply the hip joint. Local anaesthetic will be injected around the hips nerve supply using either ultrasound, loss of resistance or electrical nerve stimulator to guide the positioning of the needle on patients due for elective total hip replacement. The patient will then be observed for 30 minutes and the patient ability to move or feel the upper leg will recorded. A standard anaesthetic and a hip replacement operation will then be performed. Standard pain relief protocols will be used the operation and after the operation. After the operation we will record the amount of morphine used and how happy the patients have been with their treatment at 6 hours after the operation and at 24 hours after the operation. The first day the patient is able to walk on their new hip replacement will also be recorded.

Enrollment

269 estimated patients

Sex

All

Ages

35 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective primary total hip arthroplasty under general anaesthesia
  • ASA<=4
  • Able to give informed consent
  • Able to cooperate with sensory and motor testing of lower limb function

Exclusion criteria

  • Abnormal clotting screen (coagulopathy) or thrombocytopenia (<100,000)
  • Acute mental test score of <=7 at any time pre or post operatively
  • Allergy to local anaesthetic
  • Signs, symptoms or laboratory evidence of local infection or systemic sepsis
  • No pre-existing neurological deficit (sensory or motor) affecting lower limb
  • Patients with lower limb amputations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

269 participants in 3 patient groups, including a placebo group

loss of resistance
Placebo Comparator group
Description:
Anterior psoas compartment nerve block inserted using loss of resistance
Treatment:
Procedure: loss of resistance
nerve stimulator
Active Comparator group
Description:
Anterior psoas compartment nerve block inserted using nerve stimulator
Treatment:
Procedure: nerve stimulator
Procedure: determination of method with highest efficacy (ultrasound or nerve stimulator)
ultrasound
Active Comparator group
Description:
Anterior psoas compartment nerve block inserted using ultrasound
Treatment:
Procedure: determination of method with highest efficacy (ultrasound or nerve stimulator)

Trial contacts and locations

4

Loading...

Central trial contact

Malcolm Watson, MBChB, MRCP, FRCA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems